OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
February 04, 2009
The pending merger of Pfizer and Wyeth provides Pfizer with greater strategic diversification, particularly in biologics, but only minimally addresses its generics exposure in the near term.
February 02, 2009
The pharmaceutical majors forward projects in biocatalysis, solvent replacement, and other approaches in green chemistry.
January 22, 2009
The US Department of Health and Human Services's Biomedical Advanced Research and Development Authority has awarded Novartis a contract valued up to $486 million over eight years to support the design, construction, validation, and licensing of a US cell-based influenza vaccine manufacturing facility in Holly Springs, North Carolina.
January 15, 2009
Frank Torti, currently principal deputy commissioner and chief scientist of the US Food and Drug Administration, will take over as FDA's acting commissioner next week, according to an official with the US Department of Health and Human Services (HHS).
January 08, 2009
The generic-drug manufacturer Actavis reached an agreement on a consent decree of permanent injunction with the US Food and Drug Administration regarding the company?s US subsidiary Actavis Totowa LLC.
January 07, 2009
Outsourcing sterile manufacturing involves an integrated approach in product life-cycle management.